Jobs Alexander, Brünjes Kerstin, Katalinic Alexander, Babaev Valentin, Desch Steffen, Reppel Michael, Thiele Holger
Department of Cardiology, Angiology and Intensive Care Medicine, Medical Clinic II, University Heart Center Lübeck, Ratzeburger Allee 160, 23538, Lübeck, Germany.
German Centre for Cardiovascular Research (DZHK), Partner Site Hamburg/Kiel/Lübeck, Lübeck, Germany.
Heart Vessels. 2017 Jul;32(7):856-864. doi: 10.1007/s00380-017-0944-0. Epub 2017 Jan 23.
Inferior vena cava (IVC) diameter can be used to approximate right atrial pressure in patients admitted for acute decompensated heart failure (ADHF). Recent studies linked IVC dilation to an increased risk of early re-admission and short-term mortality. Moreover, renal insufficiency (RI) is an established risk factor for mortality in ADHF and is associated with congestion. We hypothesized that the IVC diameter is a marker of all-cause mortality but its prognostic impact may be influenced by kidney function. We analyzed data of 1101 patients admitted for ADHF with available echocardiography of the IVC by chart review and death registry linkage. Patients were dichotomized according to a cut-off value of 21 mm. Cox proportional hazards model was used to identify mortality predictors. A dilated IVC was detected in 474 (43.1%) patients. Overall, 400 (36.3%) patients died within 3 years. All-cause mortality was significantly higher in patients with dilated IVC [hazard ratio 1.45 (confidence interval 1.21-1.74); p < 0.001]. However, a dilated IVC was only associated with all-cause mortality in patients with RI function [hazard ratio 1.60 (confidence interval 1.26-2.03); p < 0.001] but not in patients with a preserved kidney function [hazard ratio 1.04 (confidence interval 0.72-1.50); P = 0.84]. IVC diameter was identified as an independent predictor for all-cause mortality in a Cox proportional hazards model with a significant interaction between IVC diameter and baseline kidney function. In conclusion, IVC dilation is a marker of high mortality risk in patients admitted for ADHF. However, this observation was confined to patients with RI.
下腔静脉(IVC)直径可用于估算因急性失代偿性心力衰竭(ADHF)入院患者的右心房压力。近期研究表明,IVC扩张与早期再入院风险增加及短期死亡率升高有关。此外,肾功能不全(RI)是ADHF患者死亡的既定风险因素,且与充血相关。我们推测,IVC直径是全因死亡率的一个标志物,但其预后影响可能受肾功能影响。我们通过病历审查和死亡登记链接分析了1101例因ADHF入院且有IVC超声心动图数据的患者。根据21毫米的临界值将患者分为两组。采用Cox比例风险模型确定死亡率预测因素。474例(43.1%)患者检测到IVC扩张。总体而言,400例(36.3%)患者在3年内死亡。IVC扩张患者的全因死亡率显著更高[风险比1.45(置信区间1.21 - 1.74);P < 0.001]。然而,IVC扩张仅与RI功能患者的全因死亡率相关[风险比1.60(置信区间1.26 - 2.03);P < 0.001],而与肾功能正常患者无关[风险比1.04(置信区间0.72 - 1.50);P = 0.84]。在Cox比例风险模型中,IVC直径被确定为全因死亡率的独立预测因素,IVC直径与基线肾功能之间存在显著交互作用。总之,IVC扩张是ADHF入院患者高死亡风险的一个标志物。然而,这一观察结果仅限于RI患者。